Comments
Shasun Pharmaceuticals and SeQuent Scientific’s joint venture firm Alivira Animal Health Ltd has picked up 60 per cent stake in Turkey’s Provet Veterinary Products for an undisclosed sum.
“Alivira Animal Health Ltd has entered into an agreement to acquire 60 per cent stake in Provet Veterinary Products, Turkey,” SeQuent Scientific said in a BSE filing today.
Commenting on the announcement, SeQuent CEO Manish Gupta said: “Provet provides us the right platform to aggressively expand our veterinary formulations business in the MENA and CEE regions”
The deal is expected to close in October 2014.
“The acquisition fast-tracks Alivira’s vision to become formidable player in global veterinary business,” the company said adding that with the agreement, Alivira gets access to the $400-million Turkish veterinary market.
Shasun Pharmaceuticals and SeQuent Scientific formed the joint venture to develop, manufacture and sell veterinary products, including both API (active pharmaceutical ingredients) and formulations to cater to the global market.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.